Roche’s Hepatitis Drug Patent Revoked by India’s Intellectual Property Appellate Board

In a major win [http://india.nydailynews.com/newsarticle/bb7f0b4b32e0dfe8f7ffe77002886b7e/india-revokes-roche-hepatitis-patent#ixzz2BCAsXcTi] for Indian drug companies which manufacture generic drugs for major ailments, the India’s Intellectual Property Appellate Board revoked Swiss giant Roche’s patent for a hepatitis C drugs.  This means that the patent that could have prevented